World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0024108618
Reproduction Date:

Title: Elorac  
Author: World Heritage Encyclopedia
Language: English
Subject: Aderis Pharmaceuticals, Zonite Products Corporation, Qualitest, Cortex Pharmaceuticals, Melior Discovery
Publisher: World Heritage Encyclopedia


Elorac, Inc.
Privately Held Company
Industry pharma
Founded August 2007
Headquarters Vernon Hills, Illinois, USA
Key people
Joel E. Bernstein, M.D., Christopher J. Gabanski, Barry Hollingsworth, John E. Kallal, Ph.D., Rhonda Pavicich
Number of employees
Slogan Specialists in the Science of Skin Care

Elorac, Inc. is a specialty pharmaceutical company focused on advancing treatments in dermatology. It is based in Vernon Hills, Illinois. According to the company’s website, Elorac specializes in prescription based dermatology products, with a focus on medications used in the treatment of psoriasis, actinic keratosis, acne and other skin disorders.

Elorac was founded by Joel E. Bernstein, M.D., the Executive Chairman of Elorac and a leading authority in dermatology. He is a successful entrepreneur with a long track record of developing and commercializing novel medicines, having founded or co-founded several companies, which have sold for more than an estimated $1 billion in the aggregate. Before starting Elorac, Dr. Bernstein was the founder, Chairman, and Chief Executive Officer of GenDerm Corporation, a pharmaceutical company that was acquired by Medicis Pharmaceutical Corporation in 1997 for an estimated $80 million.[1] He was also the founder and non-executive chairman of Sirius Laboratories, Inc., a dermatological products company acquired by DUSA Pharmaceuticals in 2006 for an estimated $30 million.[2][3] Dr. Bernstein also co-founded Ovation Pharmaceuticals in 2000, which was sold to Lundbeck in 2009 for an estimated $900 million,[4][5] and founded Winston Pharmaceuticals, a public company involved in the research of novel pain relief drugs.[6] Previously, Dr. Bernstein was head of dermatopharmacology at Northwestern University Medical School and the University of Chicago Pritzker School of Medicine. Dr. Bernstein has also held senior scientific positions at Abbott Laboratories and Schering-Plough Corporation. He has authored more than 125 scientific publications and holds over 150 patents. Dr. Bernstein received a B.A. from Carleton College and an M.D. from the University of Chicago Pritzker School of Medicine, where he received the Roche Award for ranking first in his class. He completed specialty-training programs in both dermatology and clinical pharmacology at the University of Chicago.

The company’s website states that it currently markets products for psoriasis, wart and dermatitis and that it expects to introduce products for acne, fungal diseases, actinic keratosis and management of diabetic skin over the forthcoming year. According to the website, the company focuses on the development of innovative, late-stage dermatological products that require relatively small R&D expenditures, as well as the selective acquisition and licensing of late-stage product candidates and technologies.

Financial information about the company is not available because the company is privately held.

External links

  • Company's Official Website


  1. ^
  2. ^
  3. ^
  4. ^
  5. ^
  6. ^
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.